Microorganisms' resistance to antibacterial drugs is now a major threat to human health and public health. The aim of the work was to conduct a comparative study of the species composition and resistance to antimicrobial treatments of microorganisms isolated from patients during the pandemic of the new coronavirus infection in 2020 with that from patients in 2019. The work examined bacterial strains isolated from patients with bacterial complications from COVID-19 in the intensive care unit of the Infectious Diseases Center in 2020 and from patients of the same departments treated before the pandemic of new coronavirus infection in 2019. It has been found that the species composition and resistance of microorganisms, received from patients during the pandemic in 2020, differs from those received from patients of the same departments of the same hospital in 2019. The number of polyresistent and panresistent microorganisms has increased significantly, bacterial microflora redistributed to responsible bronchopulge complications, in biomaterial, including bronchoalveolar lavage, increased the number of yeast fungi. Monitoring of microbiological strains will allow us to analyze the structure of pathogens in a particular unit, levels of their resistance to antimicrobials, as well as to identify the distribution mechanisms of microflora. The findings will facilitate the prescribing of rational empirical antimicrobial therapy and the planning of proactive measures to prevent the spread of hospital infection.
Relevance The World Health Organization has provided a list of resistant bacteria that pose the greatest threat to society. Among them, the most important (critically high priority level) are Pseudomonas aeruginosa and Acinetobacter baumannii strains resistant to carbapenems, as well as enterobacteriaceae producing extended spectrum beta-lactamases and carbapenemases.Aim. To conduct a comparative analysis of the sensitivity to chlorhexidine of multiply-resistant gram-negative bacteria, the causative agents of infectious conditions in patients of various medical organizations, and to study the relationship between the presence of resistance genes and the minimum inhibitory concentration of chlorhexidine.Materials & methods. The study included 138 Gram-negative multidrug-resistant strains isolated during 2018–2019 from various clinical specimens. Susceptibility of the isolates to antibiotics were determined using Vitek-2 compact and Phoenix М50, susceptibility to chlorhexidine were determined by agar dilution method. The resistance genes were detected by the real-time PCR method.Results. The lowest level of resistance to chlorhexidine was determined in E. coli strains (MIC90 16 mg/l), other strains were highly resistant: MIC90 of P. aeruginosa and A. baumannii – 128 mg/l, K. pneumoniae, E. cloacae и P. mirabilis – 256 mg/l. The highest frequency of detection of carbapenemase genes observed in K. pneumoniae strains – 56.0% and P. aeruginosa – 48.1%. High prevalence of cepA gene was found out (the strains of enterobacteria – 47.8%, A. baumannii – 42.9%), genes qacE, qacEΔ1 were more often detected in non-fermenting Gram-negative bacteria then in enterobacteria. Conclusion. According to the results of our study, we did not reveal a significant correlation between the presence or absence of resistance genes and MIC of chlorhexidine in Gram-negative bacteria. However, taking into account complex mechanism of the adaptive response of bacteria to the effects of chlorhexidine, and to implement the concept of preventing health care-associated infections, it is proposed to continue dynamic monitoring of the resistance of microorganisms to antiseptics, disinfectants and antibiotics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.